Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
Julia ML Brotherton, Michael Malloy, Alison C Budd, Marion Saville, Kelly T Drennan, Dorota M Gertig
Papillomavirus Research | ELSEVIER SCIENCE BV | Published : 2015
We thank Genevieve Chappell, Cathryn May, Karen Winch and the information technology team at the Victorian Cytology Service (VCS Inc) for assisting with data extraction and testing, and staff at the Data Linkage Unit at the AIHW for conducting the data linkage. The VCCR is fully funded by the Victorian Department of Health and operated by the VCS. The NHVPR is owned by the Australian Government Department of Health and operated by the VCS.